A conversation with Vinay Prasad, MD: To 'first, do no harm,' you must start with good evidence

Research output: Contribution to specialist publicationArticle

Abstract

The intrepid young oncologist's criticism of cancer screening and surrogate endpoints has stirred up controversy. He says he just wants drugmakers, others to meet high standards of evidence.

Original languageEnglish (US)
Volume2016
NoOCT
Specialist publicationManaged Care
StatePublished - 2016

ASJC Scopus subject areas

  • Medicine(all)
  • Health Policy
  • Public Health, Environmental and Occupational Health

Fingerprint Dive into the research topics of 'A conversation with Vinay Prasad, MD: To 'first, do no harm,' you must start with good evidence'. Together they form a unique fingerprint.

  • Cite this